Home
Before & After
Products
Contact
.
.
.
.

Select Page

Find a Clinic

International

Electronic Instructions for Use (e-IFU)

Thailand

1.0ml

1.2ml

1.0ml

1.2ml

Download Adobe Reader

† Contact the company for more information.

HOME BEFORE & AFTER PRODUCTS

CONTACT DIRECTIONS FOR USE Privacy Policy

Thanks for finding us.
Ready to find yourself?

CE Mark

Revanesse® Pure™+ has CE Mark as a hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 4 weeks

Revanesse® Kiss™+ has CE mark as a cross-linked hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Ultra™+ has CE Mark as a cross-linked hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Contour™+ has CE Mark as a cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Outline™ + has CE Mark as a cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse Shape+ has CE Mark as a cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

FDA

Revanesse® Lips™+ is an FDA approved hyaluronic acid dermal filler that can be used for submucosal implantation for lip augmentation in patients 22 years of age or older.

Revanesse® Versa™+ is an FDA approved hyalurolic acid dermanl filler indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults 22 years of age or more.

Are there any reasons (contraindications) I should not receive a Revanesse® Versa™+ or Revanesse® Lips™+ injection?

You should not be treated if you:

Are pregnant or breastfeeding, as the safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied
Have a history of hypertrophic scarring or keloid formation
Have evidence of scars at the intended treatment sites
Have acne and/or other inflammatory diseases of the skin, such as rosacea, seborrheic dermatitis, and psoriasis,
Have allergic history including: severe allergic reactions (anaphylaxis), heightened immune responses to common allergens, especially inhaled allergens and food allergens (atopy), allergy to hyaluronic acid products, allergy to lidocaine, Streptococcal proteins or have plans to undergo administration of graded doses of allergens (desensitization therapy) during treatment with Revanesse®.
Have acute or chronic skin disease, such as seborrheic dermatitis or rosacea, in or near the injection sites, or any infection or unhealed wound of the face
Are under concomitant anticoagulant therapy, antiplatelet therapy, or have a history of bleeding disorders, clotting disorders such as hemophilia or connective tissue disorders such as systemic lupus erythematosus

If you are under the age of 22 you should not be treated with a Revanesse® dermal filler.

It’s not recommended to use Revanesse® dermal fillers in conjunction with a laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with Over-the-counter (OTC) wrinkle products or prescription wrinkle treatments within 4 weeks prior to treatment, as there is a possible risk of inflammation or infection at the treatment site.

What are the risks?

The most common reported side effects are bleeding, bruising, swelling, and pain.
Other risks that are less likely, but may occur, include: Acne-like skin eruptions, skin sensitivity (rash, itching, tenderness), skin infection, damage to nerves or blood vessels, skin lumpiness, scarring, skin necrosis, hyperpigmentation, reactivation of herpes infection (blisters or skin sores).

If you have an adverse reaction or side effect that persists for one week or more after treatment with a Revanesse® dermal filler, please contact your healthcare provider.

Warning: One of the risks of being injected with any dermal filler is unintentional injection into a blood vessel. These complications, which have been reported with facial injectable fillers, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin.

Patient Assistance Information:

If you require immediate medical assistance, please contact your health care provider. For further assistance, please contact Prollenium Medical Technologies Inc. at 1-866-353-3017 (24 hours a day).

For more information about Revanesse® Versa™ or Revanesse® Lips™, please see their Directions for Use or speak to your health care provider.

Health Canada

Revanesse® Pure™+ is a Health Canada approved hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 4 weeks.

Revanesse® Kiss™+ is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 6-12 months. Revanesse® Kiss™+ is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for submucosal implantation for lip augmentation.

Revanesse® Ultra ™+ is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Contour™ + is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Outline™ + is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

Revanesse® Shape™+ is a Health Canada approved cross-linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

©2024 Prollenium Medical Technologies, Inc. PN15002 Rev04

You are now leaving the Revanesse® International website